ACUTEBIO Trademark

Trademark Overview

On Friday, March 18, 2022, a trademark application was filed for ACUTEBIO with the United States Patent and Trademark Office. The USPTO has given the ACUTEBIO trademark a serial number of 97318671. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, July 22, 2024. This trademark is owned by AcuteBio LLC. The ACUTEBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of pharmaceuticals featuring therapeutic agents
acutebio

General Information

Serial Number97318671
Word MarkACUTEBIO
Filing DateFriday, March 18, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

Pseudo MarkACUTE BIO
Goods and ServicesResearch and development in the field of pharmaceuticals featuring therapeutic agents

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAcuteBio LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameAcuteBio LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION ENTERED
Wednesday, March 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 30, 2022ASSIGNED TO EXAMINER
Monday, January 9, 2023NON-FINAL ACTION WRITTEN
Monday, January 9, 2023NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 1 FILED
Wednesday, January 24, 2024SOU EXTENSION 1 GRANTED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 22, 2024SOU EXTENSION 2 FILED
Monday, July 22, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

acutebio therapeutic agents featuring pharmaceuticals development field research